256 related articles for article (PubMed ID: 15927814)
1. A novel method to control the balance of skin microflora Part 2. A study to assess the effect of a cream containing farnesol and xylitol on atopic dry skin.
Katsuyama M; Kobayashi Y; Ichikawa H; Mizuno A; Miyachi Y; Matsunaga K; Kawashima M
J Dermatol Sci; 2005 Jun; 38(3):207-13. PubMed ID: 15927814
[TBL] [Abstract][Full Text] [Related]
2. A novel method to control the balance of skin microflora. Part 1. Attack on biofilm of Staphylococcus aureus without antibiotics.
Katsuyama M; Ichikawa H; Ogawa S; Ikezawa Z
J Dermatol Sci; 2005 Jun; 38(3):197-205. PubMed ID: 15927813
[TBL] [Abstract][Full Text] [Related]
3. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
4. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.
Leung DY; Hanifin JM; Pariser DM; Barber KA; Langley RG; Schlievert PM; Abrams B; Hultsch T
Br J Dermatol; 2009 Aug; 161(2):435-43. PubMed ID: 19416245
[TBL] [Abstract][Full Text] [Related]
5. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study.
Gueniche A; Knaudt B; Schuck E; Volz T; Bastien P; Martin R; Röcken M; Breton L; Biedermann T
Br J Dermatol; 2008 Dec; 159(6):1357-63. PubMed ID: 18795916
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization.
Kedzierska A; Kapińska-Mrowiecka M; Czubak-Macugowska M; Wójcik K; Kedzierska J
Br J Dermatol; 2008 Dec; 159(6):1290-9. PubMed ID: 18795934
[TBL] [Abstract][Full Text] [Related]
7. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
Hebert AA
Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
[TBL] [Abstract][Full Text] [Related]
8. Objective evaluation of the efficacy of daily topical applications of cosmetics bases using the hairless mouse model of atopic dermatitis.
Matsumoto K; Mizukoshi K; Oyobikawa M; Ohshima H; Sakai Y; Tagami H
Skin Res Technol; 2005 Aug; 11(3):209-17. PubMed ID: 15998334
[TBL] [Abstract][Full Text] [Related]
9. Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild-to-moderate atopic dermatitis.
Aschoff R; Schwanebeck U; Bräutigam M; Meurer M
Exp Dermatol; 2009 Jan; 18(1):24-9. PubMed ID: 18637133
[TBL] [Abstract][Full Text] [Related]
10. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial.
Canpolat F; Erkoçoğlu M; Tezer H; Kocabaş CN; Kandi B
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1989-93. PubMed ID: 23242727
[TBL] [Abstract][Full Text] [Related]
11. Effects of topical gluco-oligosaccharide and collagen tripeptide F in the treatment of sensitive atopic skin.
Berardesca E; Abril E; Serio M; Cameli N
Int J Cosmet Sci; 2009 Aug; 31(4):271-7. PubMed ID: 19496838
[TBL] [Abstract][Full Text] [Related]
12. A Role of Staphyococcus aureus, Interleukin-18, Nerve Growth Factor and Semaphorin 3A, an Axon Guidance Molecule, in Pathogenesis and Treatment of Atopic Dermatitis.
Ikezawa Z; Komori J; Ikezawa Y; Inoue Y; Kirino M; Katsuyama M; Aihara M
Allergy Asthma Immunol Res; 2010 Oct; 2(4):235-46. PubMed ID: 20885908
[TBL] [Abstract][Full Text] [Related]
13. Influence of narrow-band UVB phototherapy on cutaneous microbiota of children with atopic dermatitis.
Silva SH; Guedes AC; Gontijo B; Ramos AM; Carmo LS; Farias LM; Nicoli JR
J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1114-20. PubMed ID: 16987268
[TBL] [Abstract][Full Text] [Related]
14. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
Gollnick H; Kaufmann R; Stough D; Heikkila H; Andriano K; Grinienko A; Jimenez P;
Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis.
Gonzalez ME; Schaffer JV; Orlow SJ; Gao Z; Li H; Alekseyenko AV; Blaser MJ
J Am Acad Dermatol; 2016 Sep; 75(3):481-493.e8. PubMed ID: 27543211
[TBL] [Abstract][Full Text] [Related]
16. Instrumental and dermatologist evaluation of the effect of glycerine and urea on dry skin in atopic dermatitis.
Lodén M; Andersson AC; Andersson C; Frödin T; Oman H; Lindberg M
Skin Res Technol; 2001 Nov; 7(4):209-13. PubMed ID: 11737814
[TBL] [Abstract][Full Text] [Related]
17. Is topical antimycotic treatment useful as adjuvant therapy for flexural atopic dermatitis: randomized, double-blind, controlled trial using one side of the elbow or knee as a control.
Wong AW; Hon EK; Zee B
Int J Dermatol; 2008 Feb; 47(2):187-91. PubMed ID: 18211496
[TBL] [Abstract][Full Text] [Related]
18. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
19. [The role of bacteria on facial rosacea-like dermatitis in adult type atopic dermatitis].
Noguchi T; Mukai H; Nishioka K; Nishiyama S
Nihon Hifuka Gakkai Zasshi; 1990 Aug; 100(9):929-34. PubMed ID: 2259005
[TBL] [Abstract][Full Text] [Related]
20. Bacterial burden of worn therapeutic silver textiles for neurodermitis patients and evaluation of efficacy of washing.
Daeschlein G; Assadian O; Arnold A; Haase H; Kramer A; Jünger M
Skin Pharmacol Physiol; 2010; 23(2):86-90. PubMed ID: 20016250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
